Pacific Biosciences of California Inc (PACB)

[Paulieme]

Pacific Biosciences of California CEO Michael Hunkapiller Acquires 100,000 Shares (PACB)
Posted by Joseph Griffin on Dec 13th, 2013
Pacific Biosciences of California (NASDAQ:PACB) CEO Michael Hunkapiller purchased 100,000 shares of Pacific Biosciences of California stock on the open market in a transaction dated Thursday, December 12th. The shares were purchased at an average cost of $4.13 per share, with a total value of $413,000.00. Following the acquisition, the chief executive officer now directly owns 1,800,000 shares in the company, valued at approximately $7,434,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Pacific Biosciences of California (NASDAQ:PACB) opened at 4.52 on Friday. Pacific Biosciences of California has a 52-week low of $1.53 and a 52-week high of $6.50. The stock’s 50-day moving average is $4.11 and its 200-day moving average is $3.70. The company’s market cap is $299.0 million.

Pacific Biosciences of California (NASDAQ:PACB) last posted its quarterly earnings results on Tuesday, October 22nd. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by $0.01. The company had revenue of $7.40 million for the quarter, compared to the consensus estimate of $7.08 million. During the same quarter last year, the company posted ($0.41) earnings per share. Pacific Biosciences of California’s revenue was up 164.3% compared to the same quarter last year. On average, analysts predict that Pacific Biosciences of California will post $-1.25 earnings per share for the current fiscal year.

Separately, analysts at Maxim Group raised their price target on shares of Pacific Biosciences of California from $4.00 to $8.00 in a research note to investors on Thursday, September 26th. They now have a “buy” rating on the stock.

Pacific Biosciences, Inc develops Deoxyribonucleic Acid (NASDAQ:PACB) sequencing platform
http://tickerreport.com/banking-finance/90083/pacific-biosciences-of-california-ceo-michael-hunkapiller-acquires-100000-shares-pacb/